TRPC3 (canonical transient receptor potential protein 3) has been suggested to be a component of cation channel complexes that are targeted to cholesterol-rich lipid membrane microdomains. In the present study, we investigated the potential role of membrane cholesterol as a regulator of cellular TRPC3 conductances. Functional experiments demonstrated that cholesterol loading activates a non-selective cation conductance and a Ca2+ entry pathway in TRPC3-overexpressing cells but not in wild-type HEK-293 (human embryonic kidney 293) cells. The cholesterol-induced membrane conductance exhibited a current-to-voltage relationship similar to that observed upon PLC (phospholipase C)-dependent activation of TRPC3 channels. Nonetheless, the cholesterol-activated conductance lacked negative modulation by extracellular Ca2+, a typical feature of agonist-activated TRPC3 currents. Involvement of TRPC3 in the cholesterol-dependent membrane conductance was further corroborated by a novel dominant-negative strategy for selective blockade of TRPC3 channel activity. Expression of a TRPC3 mutant, which contained a haemagglutinin epitope tag in the second extracellular loop, conferred antibody sensitivity to both the classical PLC-activated as well as the cholesterol-activated conductance in TRPC3-expressing cells. Moreover, cholesterol loading as well as PLC stimulation was found to increase surface expression of TRPC3. Promotion of TRPC3 membrane expression by cholesterol was persistent over 30 min, while PLC-mediated enhancement of plasma membrane expression of TRPC3 was transient in nature. We suggest the cholesterol content of the plasma membrane as a determinant of cellular TRPC3 activity and provide evidence for cholesterol dependence of TRPC3 surface expression.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1449990 | PMC |
| http://dx.doi.org/10.1042/BJ20051246 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Distribution of TRPC1, TRPC3, and TRPC6 in the human thyroid.
Pathol Res Pract
December 2024
Institute for Anatomy and Cell Biology, Saarland University, Homburg, Saar 66421, Germany. Electronic address:
Background: Little is known about the protein expression of the transient receptor potential canonical (TRPC) channels 1, 3, and 6 in the thyroid. Research in human tissue is insufficient. Our aim was to investigate the distribution of TRPC1, 3, and 6 in the healthy human thyroid.
View Article and Find Full Text PDFPyr3 inhibits cell viability and PKCα activity to suppress migration in human bladder cancer cells.
Eur J Pharmacol
February 2025
Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan. Electronic address:
Article Synopsis
- Bladder cancer is more common in men and has high recurrence rates, particularly for non-muscle-invasive forms.
- Transient receptor potential canonical channels (TRPCs), especially TRPC3, influence cancer cell behavior through calcium signaling, and the study investigates the effects of the TRPC3 inhibitor Pyr3 on bladder cancer cells.
- Pyr3 treatment led to reduced cell viability, migration, and specific protein levels associated with cancer progression, indicating its potential as a therapeutic agent for bladder cancer by targeting PKC signaling.
Evaluation of immunohistochemical TRPC3 and TRPC6 expression patterns in human endometriosis.
Ann Anat
February 2025
Saarland University Medical Center (UKS), Department of Gynecology and Obstetrics, Homburg 66424, Germany.
Background: Although to date the pathogenesis of endometriosis remains largely unexplained, it is known that processes of migration, proliferation and revascularization and thus calcium as a messenger substance play an important role. Consecutively, the present study examines the immunohistochemical expression of the calcium transient receptor potential channels 3 and 6 (TRPC3 and TRPC6) in ectopically located (outside the uterine cavity) endometrial tissue.
Methods: Laparoscopically collected and histomorphologically verified endometriosis tissues from several different intraabdominal locations were examined (n = 20) and immunohistochemical stainings were performed with anti-TRPC3 and anti-TRPC6 antibodies (Alomone Labs, Jerusalem).
Discovery of a potent and selective TRPC3 antagonist with neuroprotective effects.
Bioorg Med Chem
January 2025
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, United States. Electronic address:
The TRPC3 protein plays a pivotal role in calcium signaling, influencing cell function. Aberrant TRPC3 expression is implicated in various pathologies, including cardiovascular diseases, tumors, and neurodegeneration. Despite its functional similarities with TRPC6 and TRPC7, TRPC3 exhibits distinct roles in disease contexts.
View Article and Find Full Text PDFDeficiency of endothelial TRPV4 cation channels ameliorates experimental abdominal aortic aneurysm.
Eur J Pharmacol
January 2025
Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China; Hunan Provincial Key Laboratory of Cardiovascular Research, Central South University, Changsha, 410013, Hunan, China. Electronic address:
Article Synopsis
- Researchers are investigating the role of transient receptor potential (TRP) ion channels in abdominal aortic aneurysm (AAA), a condition that can be deadly if ruptured.
- They utilized mouse models to study how specific TRP channels, particularly TRPV4, affect AAA development and what signaling pathways are dysfunctional.
- The study found that while some TRP channels had no impact on AAA, targeting endothelial TRPV4 could be a promising therapeutic strategy, as its activation was linked to cell apoptosis and AAA progression.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!